More than 50 experts call for strengthening training in Primary Care on pulmonary fibrosis in Spain

A report of more than 50 experts calls for improving early diagnosis and training in Primary Care on pulmonary fibrosis in Spain.

Add DEMÓCRATA to Google

Ask FREN

Published

3 minutes

Most read

Elecciones 29N · Encuestas

La media de las encuestas

Media a 18 de noviembre de 2026 · 17 institutos

  • PP31,4 %
  • PSOE27,4 %
  • Vox19,0 %
  • Frente Amplio6,1 %
  • ERC2,4 %
  • SALF2,0 %
01020304050ene 2024jul 2024ene 2025jul 2025ene 2026jul 2026

Media del último estudio de cada instituto en 30 días y su evolución semanal desde el 23J. Partidos con al menos un 2 %.

Todas las encuestas

Elecciones generales del 29 de noviembre · Demócrata

More than half a hundred healthcare professionals, managers, and patient representatives have drawn up a report in which they point to early diagnosis, coordination between different specialties, and equity between territories as priority axes in care for pulmonary fibrosis in Spain, highlighting the need to strengthen training in Primary Care in this field.

The report, entitled "Itinerario Fibrosis con Voz: transformando el abordaje de las enfermedades pulmonares intersticiales (EPI) en España", has been presented at an event held in the Senate, driven by the pharmaceutical company Boehringer Ingelheim. The purpose of the document is to move toward more integrated, coordinated, and person-centered care, as well as to promote early detection and a profound change in the approach to these conditions in the country.

"In conditions such as pulmonary fibrosis, in which time is a key factor, we need to move toward a care model that facilitates early suspicion and speeds up referral to the pulmonologist", the pulmonologist at Hospital Universitario Infanta Leonor in Madrid and president of Neumomadrid, Dr. Belén López-Muñiz, stated in this regard, adding, however, that "getting to the diagnosis sooner is only the first step". "It is also essential to ensure appropriate management and coordinated care", she said.

Also taking part in the meeting were the general secretary of the Spanish Society of Rheumatology (SER), Dr. Carmen Ordás; the incoming president of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR), Dr. Bernardino Alcázar; and the president of the Association of Relatives and Patients with Pulmonary Fibrosis (AFEFPI), Carlos Lines. All of them presented the report’s main conclusions and emphasized the need for a shared response among healthcare professionals, patients, and public Administrations.

To prepare the document, specialists have studied the care reality in Andalusia, Catalonia, Madrid, the Basque Country, Galicia and the Valencian Community. Based on this analysis, the main barriers in care have been identified and a roadmap has been designed with concrete proposals to optimize the diagnosis, treatment and support of people who live with these diseases. The IPIs encompass more than 200 different clinical entities and, within them, the fibrosing forms—among which idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) stand out—have a significant impact on patients’ survival and quality of life.

Delay in suspicion and diagnosis

One of the major challenges highlighted in the report is the delay in clinical suspicion and in diagnostic confirmation of pulmonary fibrosis. The presence of non-specific symptoms, such as dyspnea, persistent dry cough or a feeling of fatigue, makes it difficult to recognize in the early stages. For this reason, it is proposed to speed up referral pathways from Primary Care and to improve access to advanced diagnostic tests and to specialized multidisciplinary teams.

The document details that people with pulmonary fibrosis make at least 14 visits per year and that 93.4 percent of patients with newly diagnosed IPF requires at least one hospital admission in the five years that follow. Given differences between autonomous communities in access to specialized units, innovative therapies, clinical trials and support resources, it is proposed to strengthen collaboration networks between hospitals and to agree on homogeneous referral and follow-up criteria.

"Living with pulmonary fibrosis involves profoundly changing day to day life and facing many uncertainties from the first symptoms," Lines has specified, adding that it is necessary "for the voice of patients to be taken into account when designing healthcare care, because nobody knows better the difficulties of this journey than those who live it first-hand, who are the patients and their families".

In this situation, experts are calling for the implementation of rapid diagnostic pathways, formal recognition of multidisciplinary committees, the creation of shared registries and indicators, equitable access to therapeutic innovation, and strengthening comprehensive support for patients and their caregivers. “From Boehringer Ingelheim, we believe that listening to patients and encouraging dialogue among healthcare professionals, associations, and managers is essential to move forward in the approach to pulmonary fibrosis,” its Director of Market Access and Healthcare Management in Spain, Guillem Bruch, has said.